Author:
Bi Ying,Zhu Yifan,Ma Xiao,Xu Jiejing,Guo Yun,Huang Tianyu,Zhang Siqing,Wang Xin,Zhao Deyu,Liu Feng
Abstract
AbstractNow there is no clinical scale for early prediction of refractory Mycoplasma pneumoniae pneumonia (RMPP). The aim of this study is to identify indicators and develop an early predictive scale for RMPP in hospitalized children. First we conducted a retrospective cohort study of children with M. pneumoniae pneumonia admitted to Children’s Hospital of Nanjing Medical University, China in 2016. Children were divided into two groups, according to whether their pneumonia were refractory and the results were used to develop an early predictive scale. Second we conducted a prospective study to validate the predictive scale for RMPP in children in 2018. 618 children were included in the retrospective study, of which 73 with RMPP. Six prognostic indicators were identified and included in the prognostic assessment scale. The sensitivity of the prognostic assessment scale was 74.0% (54/73), and the specificity was 88.3% (481/545) in the retrospective study. 944 children were included in the prospective cohort, including 92 with RMPP, the sensitivity of the prognostic assessment scale was 78.3% (72/92) and the specificity was 86.2% (734/852). The prognostic assessment scale for RMPP has high diagnostic accuracy and is suitable for use in standard clinical practice.
Funder
Jiangsu Province Special Funds for Key Program
Jiangsu Province Young Medical Talents
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Jain, S. et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N. Engl. J. Med. 372(9), 835–845 (2015).
2. Korppi, M., Heiskanen-Kosma, T. & Kleemola, M. Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology 9(1), 109–114 (2004).
3. You, S. Y., Jwa, H. J., Yang, E. A., Kil, H. R. & Lee, J. H. Effects of methylprednisolone pulse therapy on refractory mycoplasma pneumoniae pneumonia in children. Allergy Asthma Immunol. Res. 6(1), 22–26 (2014).
4. Vervloet, L. A., Marguet, C. & Camargos, P. A. Infection by Mycoplasma pneumoniae and its importance as an etiological agent in childhood community-acquired pneumonias. Braz. J. Infect. Dis. Off. Publ. Braz. Soc. Infect. Dis. 11(5), 507–514 (2007).
5. Wang, X. et al. Necrotizing pneumonia caused by refractory Mycoplasma pneumonia pneumonia in children. World J. Pediat. WJP. 14(4), 344–349 (2018).
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献